Page last updated: 2024-11-07

linustatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Linustatin is a naturally occurring cyanogenic glucoside found in various plants, including flaxseed. It is composed of a sugar moiety (glucose) linked to a cyanogenic aglycone (linamarin). The synthesis of linustatin involves the enzymatic condensation of linamarin with glucose. Research on linustatin has focused on its potential biological activities. Studies have shown that linustatin possesses antioxidant properties, which may contribute to its health benefits. It has been investigated for its anti-inflammatory, anticancer, and neuroprotective effects. The presence of linustatin in flaxseed has led to interest in its potential health implications, particularly its role in reducing the risk of cardiovascular disease and cancer. Further research is ongoing to elucidate the mechanisms of action of linustatin and its potential therapeutic applications.'

linustatin: cyanogenic glucoside from linseed oil; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119301
CHEBI ID6483
MeSH IDM0079770

Synonyms (16)

Synonym
propanenitrile, 2-((6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-2-methyl-
2-((6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-2-methylpropanenitrile
72229-40-4
linustatin
C08333
2-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropanenitrile
AC1Q4QUT ,
CHEBI:6483
[2-(6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyloxy)-2-methylpropiononitrile)]
2-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-propanenitrile
2-methyl-2-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)methyl)tetrahydro-2h-pyran-2-yloxy)propanenitrile
2-[(6-o-hexopyranosylhexopyranosyl)oxy]-2-methylpropanenitrile
DTXSID80992959
Q27107219
2-methyl-2-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)propanenitrile
AKOS040752591

Research Excerpts

Overview

Linustatinase is an alpha beta dimer. Linamarase appears to be an alpha 5 beta 5 decamer.

ExcerptReferenceRelevance
"Linustatinase is an alpha beta dimer (molecular weights of alpha and beta = 39,000 and 19,000, respectively) while linamarase appears to be an alpha 5 beta 5 decamer (molecular weights of alpha and beta = 62,500 and 65,000, respectively)."( Isolation and characterization of two cyanogenic beta-glucosidases from flax seeds.
Conn, EE; Fan, TW, 1985
)
0.99
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cyanogenic glycosideA glycoside in which the aglycone contains a cyanide group. A cyanogenic glycoside can release poisonous hydrogen cyanide if acted upon by some enzyme.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
linustatin bioactivation010

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.59 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]